Schroder Investment Management Group acquired a new position in shares of U.S. Physical Therapy Inc. (NYSE:USPH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 103,300 shares of the company’s stock, valued at approximately $6,219,000. Schroder Investment Management Group owned 0.83% of U.S. Physical Therapy at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Neuberger Berman Group LLC boosted its position in U.S. Physical Therapy by 24.6% in the second quarter. Neuberger Berman Group LLC now owns 947,897 shares of the company’s stock worth $57,073,000 after buying an additional 187,395 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in U.S. Physical Therapy by 1.1% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 335,842 shares of the company’s stock worth $16,701,000 after buying an additional 3,592 shares during the last quarter. Aberdeen Asset Management PLC UK boosted its position in U.S. Physical Therapy by 65.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 321,707 shares of the company’s stock worth $19,370,000 after buying an additional 127,094 shares during the last quarter. Bank of Montreal Can bought a new position in U.S. Physical Therapy during the second quarter worth $14,047,000. Finally, Boston Partners boosted its position in U.S. Physical Therapy by 2.3% in the second quarter. Boston Partners now owns 158,773 shares of the company’s stock worth $9,560,000 after buying an additional 3,584 shares during the last quarter. Institutional investors own 98.33% of the company’s stock.

Shares of U.S. Physical Therapy Inc. (NYSE:USPH) traded up 0.09% during midday trading on Monday, hitting $64.00. 83,321 shares of the stock were exchanged. U.S. Physical Therapy Inc. has a 12-month low of $42.59 and a 12-month high of $64.89. The firm has a market cap of $801.28 million, a P/E ratio of 32.99 and a beta of 0.76. The firm has a 50 day moving average of $61.69 and a 200 day moving average of $56.42.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 4th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.02. U.S. Physical Therapy had a net margin of 6.95% and a return on equity of 12.06%. The company earned $90.40 million during the quarter, compared to the consensus estimate of $90.01 million. During the same period in the previous year, the firm earned $0.51 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 8.5% on a year-over-year basis. Equities analysts forecast that U.S. Physical Therapy Inc. will post $1.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Shareholders of record on Friday, August 19th were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Wednesday, August 17th. This represents a $0.68 dividend on an annualized basis and a yield of 1.06%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 34.87%.

Several equities analysts have commented on USPH shares. Barrington Research cut shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, August 5th. Jefferies Group set a $65.00 price target on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research report on Friday, August 5th. Finally, Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $68.00 price target for the company in a research report on Tuesday, August 9th.

In other U.S. Physical Therapy news, COO Glenn Mcdowell sold 4,047 shares of the stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $60.20, for a total transaction of $243,629.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $62.50, for a total transaction of $125,000.00. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy Inc. (NYSE:USPH).

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.